Courtney O'Leary

Head of Investor Relations

Equibles does not estimate personal net worth.

Get an email with a short summary when Amylyx Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get AMLX alerts

About Courtney O'Leary

Courtney O'Leary is recorded as Head of Investor Relations at Amylyx Pharmaceuticals, Inc. (AMLX). Courtney O'Leary has spoken on 1 earnings call across 1 company, most recently for Amylyx Pharmaceuticals, Inc. on November 5, 2026. Amylyx Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Amylyx Pharmaceuticals, Inc. includes Joshua Cohen (CEO and Board Member), Justin Klee (CEO and Board Member), James Frates (CFO) and 3 others.

Courtney O'Leary on recent calls

“Good morning, and thank you all for joining us today to discuss our third quarter 2026 financial results and business updates.”

Head of Investor Relations, Amylyx Third Quarter 2026 Earnings Conference Call · November 5, 2026

Affiliation history

Amylyx Pharmaceuticals, Inc. (AMLX)
Head of Investor Relations

Transcript header (unverified)

Current

Company network

Amylyx Pharmaceuticals, Inc.

AMLX

Current role

Drug Manufacturers - Specialty & Generic · Healthcare

Head of Investor Relations

1 appearance Latest appearance 2026-11-05

View calls and events

Leadership on record at Amylyx Pharmaceuticals, Inc.

Joshua Cohen CEO, Board Member
Justin Klee CEO, Board Member
James Frates CFO
Gina M. Mazzariello General Counsel
George Mclean Milne Jr Board Member
Paul Fonteyne Board Member

Recent activity

Earnings call Amylyx Third Quarter 2026 Earnings Conference Call Amylyx Pharmaceuticals, Inc. (AMLX)
2026-11-05